Invention Grant
- Patent Title: Use of H3K9me3 modulation for enhancing cognitive function
-
Application No.: US17072539Application Date: 2020-10-16
-
Publication No.: US11311551B2Publication Date: 2022-04-26
- Inventor: Carl W. Cotman , Larry E. Overman , Shikha Snigdha
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: Cotman IP Law Group, APLC
- Main IPC: A61K31/548
- IPC: A61K31/548 ; C07D513/18 ; A61K45/06 ; A61K31/27 ; A61K31/445 ; A61K31/473 ; A61P25/28 ; A61P25/22 ; A61P25/00 ; A61K31/202 ; A61K31/522
Abstract:
Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effective in treating cognitive dysfunction in aging and age-related disorders.
Public/Granted literature
- US20210106590A1 USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION Public/Granted day:2021-04-15
Information query
